Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma

Japanese Journal of Clinical Oncology

Volumn 37, Issue 4, 2007, Pages 256-265

  Demirkan, Binnaz ^a   Alacacioglu, Ahmet ^a   Yilmaz, Ugur ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Body mass index; Breast cancer; Prognosis; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; TAMOXIFEN;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DEMOGRAPHY; DISEASE FREE SURVIVAL; ETHNIC DIFFERENCE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; RACE DIFFERENCE; TURKEY (REPUBLIC); WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; POSTMENOPAUSE; PROGNOSIS; TURKEY;

EID: 34547115728     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym023     Document Type: Article

References (62)

1. Carmichael AR, Bates T. Obesity and breast cancer: A review of the literature. Breast 2004;13:85-92.
2. Population Census 2000. Population by age group, sex and provinces in Turkey. http://www.tuik.gov.tr
3. Hodoǧlugil U, Mahley RW. Smoking and obesity make a bad problem worse: Genetics and life-style affect high density lipoprotein levels in Turks - review. Anatol J Cardiol 2006;6:60-7.
4. Türkiye'de Kadinlarda En Çok Görülen On Kanser Türü, 1999 (The most common ten female cancer types in Turkey, 1999). http://www.saglik.gov.tr/extras/istatistikler/apk2001/092.htm
5. Globocan 2002. Crude and age-standardised incidence and mortality rates of breast cancer in Turkey. http://www-dep.iarc.fr/globocan/database.htm
6. Ιzmir'in Kanser Verileri, 1996-2000 (Cancer statistics of Izmir, 1996-2000). http://www.ism.gov.tr/kidem/Tdoc3.htm
7. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: The Women's Health Initiative (United States). Cancer Causes Control 2002;13:741-51.
8. van den Brandt PA, Spiegelman D, Yaun SS, Adami HO, Beeson L, Folsom AR, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000;152:514-27.
9. Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 2002;13:325-32.
10. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001;92:720-9.
11. Ryu SY, Kim CB, Nam CM, Park JK, Kim KS, Park J, et al. Is body mass index the prognostic factor in breast cancer? A meta-analysis. J Korean Med Sci 2001;16:610-4.
12. Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Ann Intern Med 1992; 116:26-32.
13. Katoh A, Watzlaf VJ, D'Amico F. An examination of obesity and breast cancer survival in postmenopausal women. Br J Cancer 1994;70: 928-33.
14. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, et al. Body mass index as a prognostic feature in operable breast cancer: The International Breast Cancer Study Group experience. Ann Oncol 2004;15:875-84.
15. Enger SM, Greif JM, Polikoff J, Press M. Body weight correlates with mortality in early-stage breast cancer. Arch Surg 2004;139:954-8.
16. Chang S, Alderfer JR, Asmar L, Buzdar AU. Inflammatory breast cancer survival: The role of obesity and menopausal status at diagnosis. Breast Cancer Res Treat 2000;64:157-63.
17. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2005;14:2009-14.
18. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SWC, Buzdar AU. Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Int Med 1994; 120:18-25.
19. Cui Y, Whiteman MK, Flaws JA, Langenberg P, Tkaczuk KH, Bush TL. Body mass and stage of breast cancer at diagnosis. Int J Cancer 2002;98:279-83.
20. Haybittle J, Houghton J, Baum M. Social class and weight as prognostic factors in early breast cancer. Br J Cancer 1997;75:729-33.
21. Newman LA, Kuerer HM, McNeese MD, Hunt KK, Gurtner GC, Vlastos GS, et al. Reduction mammoplasty improves breast conservation therapy in patients with macromastia. Am J Surg 2001;181:215-20.
22. Mehta RR, Beattie CW, Gupta TK. Endocrine profile in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 1991;20:125-32.
23. Griggs JJ, Sorbero MES, Lyman GH. Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med 2005;165:1267-73.
24. Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 2003;95:1467-76.
25. Haslam DW, James WPT. Obesity. Lancet 2005;366:1197-209.
26. Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M, and the Comparative Risk Assessment Collaborating Group (Cancers). Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005;366:1784-93.
27. Lukanova A, Björ O, Kaaks R, Lenner P, Lindahi B, Hallmans G, et al. Body mass index and cancer: Results from the Northern Sweden Health and Disease Cohort. Int J Cancer 2005.
28. Sanisoglu SY, Oktenli C, Hasimi A, Yokusoglu M, Ugurlu M. Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey. BMC Public Health 2006;6:92.
29. Erem C, Arslan A, Hacihasanoglu A, Deger O, Topbas M, Ukinc K, et al. Prevalence of obesity and associated risk factors in a Turkish population (Trabzon city, Turkey). Obes Res 2004;12:1117-27.
30. Satman I, Yilmaz T, Sengul A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care 2002;25:1551-6.
31. Ersoy C, Imamoglu S, Tuncel E, Erturk E, Ercan I. Comparison of the factors that influence obesity prevalence in three district municipalities of the same city with different socioeconomical status: A survey analysis in an urban Turkish population. Prev Med 2005;40:181-8.
32. Kumar BN, Meyer HE, Wandel M, Dalen I, Holmboe-Ottesen G. Ethnic differences in obesity among immigrants from developing countries, in Oslo, Norway. Int J Obes 2006;30:684-90.
33. Daryani A, Berglund L, Andersson A, Kocturk T, Becker W, Vessby B. Risk factors for coronary heart disease among immigrant women from Iran and Turkey, compared to women of Swedish ethnicity. Ethn Dis 2005;15:213-20.
34. Porsch-Oezçueruemez M, Bilgin Y, Wollny M, Gediz A, Arat A, Karatay E, et al. Prevalence of risk factors of coronary heart disease in Turks living in Germany: The Giessen Study. Atherosclerosis 1999;144:185-98.
35. Mahley RW, Can S, Özbayrakçi S, Bersot TP, Tanir S, Palaoǧlu KE, et al. Modulation of high-density lipoproteins in a population in Istanbul, Turkey, with low levels of high-density lipoproteins. Am J Cordial 2005;96:547-55.
36. Discigil G, Gemalmaz A, Tekin N, Basak O. Profile of menopausal women in west Anatolian rural region sample. Maturitas 2006 (in press).
37. Key TJ, Allen NE, Spencer EA, Travis RC. Nutrition and breast cancer. Breast 2003;12:412-6.
38. Stephenson GD, Rose DP. Breast cancer and obesity: An update. Nutr Cancer 2003;45:1-16.
39. Chow LWC, Lui KL, Yin Chan JC, Ching Chan T, Ho PK, Lee WY, et al. Association between body mass index and risk of formation of breast cancer in Chinese women. Asian J Surg 2005;28:179-84.
40. McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003;21:1961-6.
41. Yin N, Wang D, Zhang H, Yi X, Sun X, Shi B, et al. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 2004;64:5870-5.
42. Caldefie-Chezet F, Damez M, de Latour M, Konska G, Mishellani F, Fusillier C, et al. Leptin: A proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun 2005;334:737-41.
43. Neels JG, Thinnes T, Loskutoff DJ. Angiogenesis in an in vivo model of adipose tissue development. Faseb J 2004;18:983-5. Epub: 14 April 2004.
44. Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes 2005;29:1308-14.
45. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153-65.
46. Rose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis and the biological actions of leptin (review). Int J Oncol 2002;21:1285-92.
47. Bulun SE, Mahendroo MS, Simpson ER. Aromatase gene expression in adipose tissue: Relationship to breast cancer. J Steroid Biochem Mol Biol 1994;49:319-26.
48. Kato T, Kameoka S, Kimura T, Nishikawa T, Kasajima T. Angiogenesis and blood vessel invasion as prognostic indicators for node-negative breast cancer. Breast Cancer Res Treat 2001;65:203-15.
49. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
50. Deb S, Amin S, Imir AG, Yilmaz MB, Suzuki T, Sasano H, et al. Estrogen regulates expression of tumor necrosis factor receptors in breast adipose fibroblasts. J Clin Endocrinol Metab 2004;89:4018-24.
51. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in marine models of obesity. Endocrinology 2005;146:4545-54.
52. Miyoshi Y, Funahashi T, Tanaka S, Taguchi T, Tamaki Y, Shimomura I, et al. High expression of leptin receptor mRNA in breast cancer tissue predicts poor prognosis for patients with high, but not low, serum leptin levels. Int J Cancer 2006;118:1414-9.
53. Goodwin PJ, Ennis M, Fantus IG, Pritchard KI, Trudeau ME, Koo J, et al. Is leptin a mediator of adverse prognostic effects of obesity in breast cancer? J Clin Oncol 2005;23:6037-42.
54. Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Helal AN, Chouchane L. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006;6:38-48.
55. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004;10:4325-31.
56. Yin N, Wang D, Zhang H, Yi X, Sun X, Shi B, et al. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 2004;64:5870-5.
57. Ozet A, Arpaci F, Ilker Yilmaz M, Ayta H, Ozturk B, Komurcu S, et al. Effects of tamoxifen on the serum leptin level in patients with breast cancer. Jpn J Clin Oncol 2001;31:424-7.
58. Purohit A, Reed MJ. Regulation of estrogen synthesis in postmenopausal women. Steroids 2002;67:979-83.
59. Anderson BO, Shyyan R, Eniu A, Smith RA, Yip CH, Bese NS, et al. Breast cancer in limited-resource countries: An overview of the breast health global initiative 2005 guidelines. Breast J 2006;12(Suppl.1): S3-15.
60. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-8.
61. Fredriks AM, van Buuren S, Sing RAH, Wit JM, Verloove-Vanhorick SP. Alarming prevalences of overweight and obesity for children of Turkish, Moroccan and Dutch origin in the Netherlands according to international standards. Acta Paediatr 2005;94:496-8.
62. Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006;95:194-8.